DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/e0600a/booming_generics_d) has announced the addition of the "Booming Generics Drug Market in India" report to their offering.
Generic drugs have become a new area of interest for pharmaceutical manufacturers. After the recession, demand for generic drugs has significantly soared due to the low cost factor. India is considered as one of the fastest growing pharmaceutical markets in the world. The introduction of product patent regime has put the industry growth on a new path. As per our new research report Booming Generics Drug Market in India, the generic drugs market in India is projected to grow at a CAGR of around 16.3% during FY 2011-FY 2013.
Our team of industry experts has found that generic drugs exports from India have seen a significant surge over the last few years. The European and African countries have been added as new destinations for exports. The US and East Asian countries will remain a vital importing destinations for Indian generic products. In future, the exports are expected to pick up pace as healthcare reform in the US and other countries will inflate demand for generic drugs.
Our experts also indicate that several new trends have crept into the industry along with developments. The report provides a complete analysis on these new trends to facilitate the client understand them and plan their investment strategies accordingly. The report also contains information about the regulatory environment that has done an outstanding job in the development of generic industry in India. Besides, it provides information of various industry roadblocks that need to be addressed for sustaining the growth trend. Thus, the report presents a true and unbiased picture of the industry and help the client in making investments decision.
The report is an outcome of comprehensive research and rational analysis of various segments like API and formulation drugs of Indian generic and pharmaceutical market. It provides statistical data and analysis of ongoing and future trends to facilitate a deep market understanding. The future projections are made after analyzing the current market scenario, past trends and ongoing developments in the market. A detailed overview of competitive landscape has also been included to provide a balanced research approach.
Key Topics Covered:
- 1. Analyst View
- 2. Research Methodology
- 3. Indian Generics Market - An Overview
- 4. Key Market Drivers
- 5. Industry Performance
- 6. Opportunities for Indian Generics Companies
- 7. Emerging Industry Trends
- 8. Regulatory Environment
- 9. Industry Restraints and Recommendations
- 10. Competitive Landscape
- List of Tables
- List of Figures
Companies Mentioned:
- Ranbaxy
- Cipla Ltd.
- Jubilant Organosys
- Sun Pharmaceuticals
- Zydus Cadila
- Dr. Reddy's Laboratories
- Lupin Ltd.
- Aurobindo Pharma
- Glenmark Pharma
- Piramal Healthcare
For more information visit http://www.researchandmarkets.com/research/e0600a/booming_generics_d
CONTACT:
Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS: Asia Pacific India
INDUSTRY KEYWORDS: Health Pharmaceutical
MEDIA:
| Logo |